US HEALTH SECRETARY KENNEDY SAYS NEW DRUG-PRICING DEALS INCLUDE $19.6BN IN COMMITMENTS TO RESHORE PHARMACEUTICAL PRODUCTION TO THE U.S. NEW DEALS AIM TO LOWER DRUG PRICES FOR AMERICANS WHILE STRENGTHENING U.S. PHARMACEUTICAL SUPPLY CHAINS AND DOMESTIC MANUFACTURING. 31-AUG-2026 03:50 PM ET